Showing results (1751-1760 of 3,794) with videos related to
Sort By:
Pageof 380
Oncoimmunology|June 7, 2018
The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cellsXinxin Li, Wenjuan Dong, Ansel P Nalin, et al.Oncoimmunology|June 7, 2018
RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancerElizabeth Ahern, Heidi Harjunpää, Jake S O'Donnell, et al.Oncoimmunology|June 7, 2018
eIF2α phosphorylation: A hallmark of immunogenic cell deathLucillia Bezu, Allan Sauvat, Juliette Humeau, et al.Oncoimmunology|June 7, 2018
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancerMagalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.Oncoimmunology|June 7, 2018
Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2Na Luo, Luigi Formisano, Paula I Gonzalez-Ericsson, et al.Oncoimmunology|January 23, 2015
Transcriptional profiling of whole blood: a rich source of immune biomarkers in cancerY Saenger, E de Moll, Y FuOncoimmunology|January 23, 2015
Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrenceLaura A Johnson, Luis Sanchez-Perez, Carter M Suryadevara, et al.Oncoimmunology|January 23, 2015
The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapyJennifer A Westwood, Phillip K Darcy, Michael H KershawOncoimmunology|January 23, 2015
Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one moleculeGijs G Zom, Dmitri V Filippov, Gijsbert A van der Marel, et al.Oncoimmunology|January 23, 2015
Targeting Galectin-1 in pancreatic cancer: immune surveillance on guardNeus Martínez-Bosch, Pilar NavarroPageof 380